The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives.
Level 5 - mechanism / opinion, no new human data
Narrative review and theoretical hypothesis paper without new empirical human data.
PubMed 24071439 · doi:10.1016/j.bbadis.2013.09.010
What was done
Narrative review and conceptual update on the Alzheimer's disease mitochondrial cascade hypothesis ten years after its initial formulation. The authors evaluate the theoretical framework in light of subsequent biomarker studies, diagnostic criteria, and clinical trial outcomes.
What was found
The abstract reports no numerical data, effect sizes, or quantitative findings. The authors assert that baseline mitochondrial function and rates of mitochondrial change determine sporadic Alzheimer's disease chronology and trigger downstream amyloid-beta accumulation, predicting that clearing brain amyloid-beta will have only a marginal impact on cognitive trajectories.
Why it matters
It offers an alternative upstream mechanistic model for sporadic late-onset Alzheimer's disease that prioritizes bioenergetic decline over primary amyloid toxicity.
Limits
This is a narrative theory paper containing no original human data, statistical analyses, or systematic search methodology in the abstract. Predictions regarding treatment efficacy represent hypothesis-driven deduction rather than tested clinical outcomes.
Cited by
- context The majority of dementia cases are caused by mitochondrial dysfunction rather than rare inherited genetic mutations.